SF Journal of Clinical Pharmacology and Research
SFCPR

Gout and Rheumatoid Arthritis: Available Options for Pharmacotherapy. Overview of World Data

Review Article Volume 2 Issue 1
Wisniewski D and Uzar I*
Corresponding Author: Uzar I

Abstract

Due to adverse effects, old-age uricosuric medications have been withdrawn only to assisted treatment of gout. Their place was taken by Xanthine Oxidase (XOI) inhibitors as the first-choice medication. Although they are easier to monitor and free from many side effects, they have a limited spectrum of associations. New-generation uricosuric medications have been included in combination therapy with XOI. They can also be used alone in the case of patients with XOI

Article Information

Journal SF Journal of Clinical Pharmacology and Research
Article Type Review Article
Volume 2
Issue 1